CD8A and Middle East respiratory syndrome: Recent reports provide some evidence of a cross-reactive CD4+ and CD8+ T cell response in patients with COVID-19 hypothesized to be due to exposure to other coronaviruses, including those from patients who have never been exposed to the SARS, Middle East respiratory syndrome (MERS), or COVID-19 coronaviruses (23).